Matthew J O'Brien1,2, Margaret R Moran2, Joyce W Tang3, Maria C Vargas2, Mary Talen4, Laura J Zimmermann1,5, Ronald T Ackermann1,2, Namratha R Kandula1,2,6. 1. Division of General Internal Medicine and Geriatrics, Northwestern University Feinberg School of Medicine, Chicago, Illinois, USA (Dr O'Brien, Ms Vargas, Dr Zimmermann, Dr Ackermann, Dr Kandula) 2. Center for Community Health, Institute for Public Health and Medicine, Northwestern University Feinberg School of Medicine, Chicago, Illinois, USA (Dr O'Brien, Ms Moran, Ms Vargas, Dr Ackermann, Dr Kandula) 3. Section of Hospital Medicine, Department of Medicine, University of Chicago Medical Center, Chicago, Illinois, USA (Dr Tang) 4. Northwestern Family Medicine Residency Program, Erie Family Health Center, Chicago, Illinois, USA (Dr Talen) 5. Erie Family Health Center, Chicago, Illinois, USA (Dr Zimmermann) 6. Department of Preventive Medicine, Northwestern University Feinberg School of Medicine, Chicago, Illinois, USA (Dr Kandula)
Abstract
PURPOSE: The purpose of this study was to explore how adults with prediabetes perceive their risk of developing diabetes and examine their preferences for evidence-based treatment options to prevent diabetes. METHODS: A qualitative study was conducted in 2 large Midwest primary care practices, involving in-depth semistructured interviews with 35 adult patients with prediabetes. RESULTS: This ethnically diverse (77% nonwhite) sample of middle-aged primary care patients exhibited multiple diabetes risk factors. Knowledge gaps about prediabetes and its medical management were pervasive. Most patients overestimated the risk of developing diabetes and were not familiar with evidence-based treatment options for prediabetes. They suggested that receiving brief, yet specific information about these topics during the study interview motivated them to act. The majority of participants considered both intensive lifestyle intervention and metformin acceptable treatment options. Many preferred initial treatment with intensive lifestyle intervention but would take metformin if their efforts at lifestyle change failed and their primary care physician recommended it. Some participants expressed wanting to combine both treatments. CONCLUSIONS: This qualitative study highlights potential opportunities to promote patient-centered dialogue about prediabetes in primary care settings. Providing patients specific information about the risk of developing diabetes and evidence-based treatment options to prevent or delay its onset may encourage action. Physicians' prediabetes counseling efforts should be informed by the finding that most patients consider both intensive lifestyle intervention and metformin acceptable treatment options.
PURPOSE: The purpose of this study was to explore how adults with prediabetes perceive their risk of developing diabetes and examine their preferences for evidence-based treatment options to prevent diabetes. METHODS: A qualitative study was conducted in 2 large Midwest primary care practices, involving in-depth semistructured interviews with 35 adult patients with prediabetes. RESULTS: This ethnically diverse (77% nonwhite) sample of middle-aged primary care patients exhibited multiple diabetes risk factors. Knowledge gaps about prediabetes and its medical management were pervasive. Most patients overestimated the risk of developing diabetes and were not familiar with evidence-based treatment options for prediabetes. They suggested that receiving brief, yet specific information about these topics during the study interview motivated them to act. The majority of participants considered both intensive lifestyle intervention and metformin acceptable treatment options. Many preferred initial treatment with intensive lifestyle intervention but would take metformin if their efforts at lifestyle change failed and their primary care physician recommended it. Some participants expressed wanting to combine both treatments. CONCLUSIONS: This qualitative study highlights potential opportunities to promote patient-centered dialogue about prediabetes in primary care settings. Providing patients specific information about the risk of developing diabetes and evidence-based treatment options to prevent or delay its onset may encourage action. Physicians' prediabetes counseling efforts should be informed by the finding that most patients consider both intensive lifestyle intervention and metformin acceptable treatment options.
Authors: Alain G Bertoni; Denise E Bonds; Susan Steffes; Eric Jackson; Lenore Crago; Aarthi Balasubramanyam; Haiying Chen; David C Goff Journal: Am Heart J Date: 2006-10 Impact factor: 4.749
Authors: X R Pan; G W Li; Y H Hu; J X Wang; W Y Yang; Z X An; Z X Hu; J Lin; J Z Xiao; H B Cao; P A Liu; X G Jiang; Y Y Jiang; J P Wang; H Zheng; H Zhang; P H Bennett; B V Howard Journal: Diabetes Care Date: 1997-04 Impact factor: 19.112
Authors: Linda S Geiss; Cherie James; Edward W Gregg; Ann Albright; David F Williamson; Catherine C Cowie Journal: Am J Prev Med Date: 2010-04 Impact factor: 5.043
Authors: Man-Huei Chang; Rodolfo Valdez; Renée M Ned; Tiebin Liu; Quanhe Yang; Ajay Yesupriya; Nicole F Dowling; James B Meigs; Michael S Bowen; Muin J Khoury Journal: Diabetes Care Date: 2011-09-20 Impact factor: 17.152
Authors: Eva Tseng; Raquel C Greer; Paul O'Rourke; Hsin-Chieh Yeh; Maura M McGuire; Ann L Albright; Jill A Marsteller; Jeanne M Clark; Nisa M Maruthur Journal: J Gen Intern Med Date: 2019-09-09 Impact factor: 5.128
Authors: Tannaz Moin; O Kenrik Duru; Norman Turk; Janet S Chon; Dominick L Frosch; Jacqueline M Martin; Kia Skrine Jeffers; Yelba Castellon-Lopez; Chi-Hong Tseng; Keith Norris; Carol M Mangione Journal: J Gen Intern Med Date: 2019-08-30 Impact factor: 6.473
Authors: Raymond Boon Tar Lim; Wei Keong Wee; Wei Chek For; Jayalakshmy Aarthi Ananthanarayanan; Ying Hua Soh; Lynette Mei Lim Goh; Dede Kam Tyng Tham; Mee Lian Wong Journal: BMC Public Health Date: 2020-01-02 Impact factor: 3.295
Authors: Wayne W Zachary; Pamela J Surkan; Tai Barber-Gumbs; Ylva Trolle Lagerros; Laura M Sena; Joel Gittelsohn; Larry W Chang Journal: JMIR Form Res Date: 2021-02-26